Interleukin-12 and photocarcinogenesis

Toxicology and Applied Pharmacology

Volumn 224, Issue 3, 2007, Pages 220-227

  Katiyar, Santosh K ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Cyclobutane pyrimidine dimers; Interleukin 12; Photocarcinogenesis; UV radiation

Indexed keywords

CYCLOBUTANE DERIVATIVE; CYCLOBUTANE PYRAMIDINE DIMER; INTERLEUKIN 12; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CELL PROLIFERATION; DNA DAMAGE; DNA REPAIR; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KNOCKOUT MOUSE; NONHUMAN; PAPILLOMA; PHOTOCARCINOGENESIS; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; SUNBURN; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME; ULTRAVIOLET RADIATION; WILD TYPE;

ANIMALS; CELL PROLIFERATION; HUMANS; INTERLEUKIN-12; MODELS, BIOLOGICAL; OXIDATIVE STRESS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

MURINAE; MUS;

EID: 35348854953     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2006.11.017     Document Type: Review

References (61)

1. Applegate L.A., Ley R.D., Alcalay J., and Kripke M.L. Identification of molecular targets for the suppression of contact hypersensitivity by ultraviolet radiation. J. Exp. Med. 170 (1989) 1117-1131
2. Brunda M.J., Luistro L., Warrier R.R., Wright R.B., Hubbard B.R., Murphy M., Wolf S.F., and Gately M.K. Antitumor and antimetastatic activity of interleukin-12 against murine tumors. J. Exp. Med. 178 (1993) 1223-1230
3. Chapman R.S., Cooper K.D., De Fabo E.C., Frederick J.E., Gelatt K.N., Hammond S.P., Hersey P., Koren H.S., Ley R.D., and Noonan F. Solar ultraviolet radiation and the risk of infectious disease. Photochem. Photobiol. 61 (1995) 223-247
4. Chen L., Chen D., Bloack E., O'Donnell M., Kufe D.W., and Clinton S.K. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the p40 subunit homodimer. J. Immunol. 159 (1997) 351-359
5. Colombo M.P., Vagliani M., Spreafico F., Parenza M., Chiodoni C., Melani C., and Stoppacciaro A. Amount of interleukin 12 available at the tumor site is critical for tumor regression. Cancer Res. 56 (1996) 2531-2534
6. Cowen E.W., and Billingsley E.M. Awareness of skin cancer by kidney transplant patients. J. Am. Acad. Dermatol. 40 (1999) 697-701
7. DiGiovanna J.J. Posttransplantation skin cancer: scope of the problem, management and role for systemic retinoid chemoprevention. Transplant Proc. 30 (1998) 2771-2775
8. Donawho C.K., and Kripke M.L. Evidence that the local effect of ultraviolet radiation on the growth of murine melanomas is immunologically mediated. Cancer Res. 51 (1991) 4176-4181
9. Fortina A.B., Caforio A.L., Piaserico S., Alaibac M., Tona F., Feltrin G., Livi U., and Peserico A. Skin cancer in heart transplant recipients: frequency and risk factor analysis. J. Heart Lung Transplant. 19 (2000) 249-255
10. Halak B.K., Maguire Jr. H.C., and Lattime E.C. Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site. Cancer Res. 59 (1999) 911-917
11. Hayes M.P., Wang J., and Norcross M.A. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes. Blood 86 (1995) 646-650
12. Heinzerling L., Dummer R., Pavlovic J., Schultz J., Burg G., and Moelling K. Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in mice. Exp. Dermatol. 11 (2002) 232-240
13. Heinzerling L., Burg G., Dummer R., Maier T., Oberholzer P.A., Schultz J., Elzaouk L., Pavlovic J., and Moelling K. Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy. Hum. Gene Ther. 16 (2005) 35-48
14. Katiyar S.K. Oxidative stress and photocarcinogenesis: strategies for prevention. In: Singh K.K. (Ed). Oxidative Stress, Disease and Cancer (2006), Imperial College Press, London 933-964
15. Katiyar S.K., and Mukhtar H. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen presenting cells and oxidative stress. J. Leukocyte Biol. 69 (2001) 719-726
16. Katiyar S.K., Korman N.J., Mukhtar H., and Agarwal R. Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J. Natl. Cancer Inst. 89 (1997) 556-566
17. Kinlen L., Sheil A., Peta J., and Doll R. Collaborative United Kingdom-Australia study of cancer in patients treated with immunosuppressive drugs. Br. J. Med. II (1979) 1461-1466
18. Kobayashi M., Fitz L., Ryan M., Hewick R.M., Clark S.C., Chan S., Loudon R., Sherman F., Perussia B., and Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170 (1989) 827-845
19. Kripke M. Photoimmunology. Photochem. Photobiol. 52 (1990) 919-923
20. Kripke M.L., Cox P.A., Alas L.G., and Yarosh D.B. Pyrimidine dimers in DNA initiated systemic immunosuppression in UV-irradiated mice. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 7516-7520
21. Maeda A., Schneider S.W., Kojima M., Beissert S., Schwarz T., and Schwarz A. Enhanced photocarcinogenesis in interleukin-12-deficient mice. Cancer Res. 66 (2006) 2962-2969
22. Manetti R., Parronchi P., Giudizi M.G., Piccinni M.P., Maggi E., Trinchieri G., and Romagnani S. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177 (1993) 1199-1204
23. Mattner F., Fischer S., Guckes S., Jin S., Kaulen H., Schmitt E., Rude E., and Germann T. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur. J. Immunol. 23 (1993) 2202-2208
24. Meeran S.M., Katiyar S., Elmets C.A., and Katiyar S.K. Silymarin inhibits UV radiation-induced immunosuppression through augmentation of interleukin-12 in mice. Mol. Cancer Ther. 5 (2006) 1660-1668
25. Meeran S.M., Mantena S.K., and Katiyar S.K. Prevention of ultraviolet radiation-induced immunosuppression by (-)-epigallocatechin-3-gallate in mice is mediated through interleukin 12-dependent DNA repair. Clinical Cancer Res. 12 (2006) 2272-2280
26. Meeran S.M., Mantena S.K., Elmets C.A., and Katiyar S.K. (-)-Epigallocatechin-3-gallate prevents photocarcinogenesis in mice through interleukin-12-dependent DNA repair. Cancer Res. 66 (2006) 5512-5520
27. Meeran S.M., Mantena S.K., Meleth S., Elmets C.A., and Katiyar S.K. Interleukin-12-deficient mice are at greater risk of ultraviolet radiation-induced skin tumors and malignant transformation of papillomas to carcinomas. Mol. Cancer Ther. 5 (2006) 825-832
28. Meunier L., Raison-Peyron N., and Meynadier J. UV-induced immunosuppression and skin cancers. Rev. Med. Interne 19 (1998) 247-254
29. Mu J., Zou J.P., Yamamoto N., Tsutsui T., Tai X.G., Kobayashi M., Herrmann S., Fujiwara H., and Hamaoka T. Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes. Cancer Res. 55 (1995) 4404-4408
30. Mukhtar H., and Elmets C.A. Photocarcinogenesis: mechanisms, models and human health implications. Photochem. Photobiol. 63 (1996) 355-447
31. Muller G., Saloga J., Germann T., Schuler G., Knop J., and Enk A.H. IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. J. Immunol. 155 (1995) 4661-4668
32. Nastala C.L., Edington H.D., McKinney T.G., Tahara H., Nalesnik M.A., Brunda M.J., Gately M.K., Wolf S.F., Schreiber R.D., and Storkus W.J. Recombinant IL-12 administration induces tumor-regression in association with IFN-γ production. J. Immunol. 153 (1994) 1697-1706
33. Otley C.C., and Pittelkow M.R. Skin cancer in liver transplant recipients. Liver Transplant. 6 (2000) 253-262
34. Robertson M.J., and Ritz J. Interleukin-12: basic biology and potential applications in cancer treatment. Oncologist 1 (1996) 88-97
35. Romerdahl C.A., Okamoto H., and Kripke M.L. Immune surveillance against cutaneous malignancies in experimental animals. Immunol. Ser. 46 (1989) 749-767
36. Rook A.H., Wood G.S., Yoo E.K., Elenitsas R., Kao D.M., Sherman M.L., Witmer W.K., Rockwell K.A., Shane R.B., Lessin S.R., and Vonderheid E.C. Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses. Blood 94 (1999) 902-908
37. Rook A.H., Zaki M.H., Wysocka M., Wood G.S., Duvic M., Showe L.C., Foss F., Shapiro M., Kuzel T.M., Olsen E.A., Vonderheid E.C., Laliberte R., and Sherman M.L. The role for interleukin-12 therapy of cutaneous T cell lymphoma. Ann. N. Y. Acad. Sci. 941 (2001) 177-184
38. Schmitt D.A., Owen-Schaub L., and Ullrich S.E. Effect of IL-12 on immune suppression and suppressor cell induction by ultraviolet radiation. J. Immunol. 154 (1995) 5114-5120
39. Schwarz T. Mechanism of UV-induced immunosuppression. Keio J. Med. 54 (2005) 165-171
40. Schwarz A., Grabbe S., Aragane Y., Sandkuhl K., Riemann H., Luger T.A., Kubin M., Trinchieri G., and Schwarz T. Interleukin-12 prevents ultraviolet B-induced local immunosuppression and overcomes UVB-induced tolerance. J. Invest. Dermatol. 106 (1996) 1187-1191
41. Schwarz A., Stander S., Berneburg M., Bohm M., Kulms D., van Steeg H., Grosse-Heitmeyer K., Krutmann J., and Schwarz T. Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nat. Cell Biol. 4 (2002) 26-31
42. Schwarz A., Maeda A., Kernebeck K., van Steeg H., Beissert S., and Schwarz T. Prevention of UV radiation-induced immunosuppression by IL-12 is dependent on DNA repair. J. Exp. Med. 201 (2005) 173-179
43. Sharma S.D., and Katiyar S.K. Dietary grape-seed proanthocyanidin inhibition of ultraviolet B-induced immune suppression is associated with induction of IL-12. Carcinogenesis 27 (2006) 95-102
44. Siders W., Wright P., Hixon J., Alvord W.G., Back T.C., Wiltrout R.H., and Fenton R.G. T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus. J. Immunol. 160 (1998) 5465-5474
45. Smith C.W., Chen Z., Dong G., Loukinova E., Pegram M.Y., Nicholas-Figueroa L., Van Waes C., Smith C.W., Chen Z., Dong G., Loukinova E., Pegram M.Y., Nicholas-igueroa L., and Van Waes C. The host environment promotes the development of primary and metastatic squamous cell carcinomas that constitutively express proinflammatory cytokines IL-1alpha, IL-6, GM-CSF, and KC. Clin. Exp. Metastasis 16 (1998) 655-664
46. Sundelin K., Roberg K., Grenman R., and Hakansson L. Effects of cytokines on matrix metalloproteinase expression in oral squamous cell carcinoma in vitro. Acta Otolaryngol. 125 (2005) 765-773
47. Tahara H., Zeh III H.J., Storkus W.J., Pappo I., Watkins S.C., Gubler U., Wolf F., Robbins P.D., and Lotze M.T. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res. 54 (1994) 182-189
48. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84 (1994) 4008-4027
49. Trinchieri G., and Scott P. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions. Res. Immunol. 146 (1995) 423-431
50. Ullrich S.E. Potential for immunotoxicity due to environmental exposure to ultraviolet radiation. Hum. Exp. Toxicol. 14 (1995) 89-91
51. Urbach F. Incidences of nonmelanoma skin cancer. Dermatol. Clin. 9 (1991) 751-755
52. Van der Leun J.C. In: Van der Leun J.C., and Tevini M. (Eds). Human Health: United Nations Environmental Program Report on the Environmental Effects of Ozone Depletion (1989), EPA, Washington, DC
53. Vink A.A., Strickland F.M., Bucana C., Cox P.A., Roza L., Yarosh D.B., and Kripke M.L. Localization of DNA damage and its role in altered antigen-presenting cell function in ultraviolet-irradiated mice. J. Exp. Med. 183 (1996) 1491-1500
54. Vink A.A., Moodycliffe A.M., Shreedhar V., Ullrich S.E., Roza L., Yarosh D.B., and Kripke M.L. The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimers. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 5255-5260
55. Voest E.E., Kenyon B.M., O'Reilly M.S., Truitt G., D'Amato R.J., and Folkman J. Inhibition of angiogenesis in vivo by interleukin 12. J. Natl. Cancer Inst. 87 (1995) 581-586
56. Wigginton J.M., Komschlies K.L., Back T.C., Franco J.L., Brunda M.J., and Wiltrout R.H. Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma. J. Natl. Cancer Inst. 88 (1996) 38-43
57. Wolf S.F., Temple P.A., Kobayashi M., Young D., Dicig M., Lowe L., Dzialo R., Fitz L., Ferenz C., and Hewick R.M. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146 (1991) 3074-3081
58. Yarosh D., Alas L.G., Yee V., Oberyszyn A., Kibitel J.T., Mitchell D., Rosenstein R., Spinowitz A., and Citron M. Pyrimidine dimer removal enhanced by DNA repair liposomes reduces the incidence of UV skin cancer in mice. Cancer Res. 52 (1992) 4227-4231
59. Yoshikawa T., Rae V., Bruins-Slot W., vand-den-Berg J.W., Taylor J.R., and Streilein J.W. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J. Invest. Dermatol. 95 (1990) 530-536
60. 53 in the onset of skin cancer. Nature 372 (1994) 773-776
61. Zou J.P., Yamatato N., Fuzii T., Takenaka H., Kobayashi M., Herrmann S.H., Wolf S.F., Fujiwara H., and Hamaoka T. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-γ production by anti-tumor T cells. Int. Immunol. 7 (1995) 1135-1145